Tacrine for senile dementia of Alzheimer's or Lewy body type.

Tacrine for senile dementia of Alzheimer's or Lewy body type.

Bibliografiset tiedot
Päätekijät:	Wilcock, G, Scott, M
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	1994

Samankaltaisia teoksia

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
Tekijä: Ballard, C, et al.
Julkaistu: (1996)

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
Tekijä: Morar, C, et al.
Julkaistu: (1983)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
Tekijä: Wilcock, G
Julkaistu: (1990)

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Tekijä: Wilcock, G, et al.
Julkaistu: (1988)

Dementia with Lewy bodies.
Tekijä: Wilcock, G
Julkaistu: (2003)

PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
Tekijä: Forsyth, D, et al.
Julkaistu: (1989)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
Tekijä: Wilcock, G
Julkaistu: (1994)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Tekijä: Appleyard, M, et al.
Julkaistu: (1987)

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
Tekijä: Forsyth, DR, et al.
Julkaistu: (1989)

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
Tekijä: Roberts, C, et al.
Julkaistu: (1998)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
Tekijä: Wilcock, G
Julkaistu: (1994)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Tekijä: Qizilbash, N, et al.
Julkaistu: (1998)

Long-term use of tacrine
Tekijä: Wilcock, G, et al.
Julkaistu: (1994)

Long-term use of tacrine.
Tekijä: Wilcock, G, et al.
Julkaistu: (1994)

TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE
Tekijä: Jones, S, et al.
Julkaistu: (1987)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
Tekijä: Hansen, L, et al.
Julkaistu: (1998)

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia
Tekijä: Alan J. Thomas, et al.
Julkaistu: (2018-03-01)

Tacrine for Alzheimer's disease.
Tekijä: Qizilbash, N, et al.
Julkaistu: (2000)

Lewy body dementia--diagnosis and treatment.
Tekijä: McKeith, I, et al.
Julkaistu: (1995)

Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
Tekijä: Ford, J, et al.
Julkaistu: (1993)

Alzheimer and vascular brain disease: Senile dementia
Tekijä: Eliasz Engelhardt, et al.

The gesture imitation test in dementia with Lewy bodies and Alzheimer's disease dementia
Tekijä: Xudong Li, et al.
Julkaistu: (2022-07-01)

Clinical experience with and side-effects of tacrine hydrochloride in Alzheimer's disease: a pilot study.
Tekijä: Forsyth, DR, et al.
Julkaistu: (1989)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Tekijä: Shifu Xiao, et al.
Julkaistu: (2019-02-01)

Dementia with Lewy bodies
Tekijä: O. S. Levin, et al.
Julkaistu: (2018-11-01)

Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type.
Tekijä: Jamieson, G, et al.
Julkaistu: (1992)

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
Tekijä: Pearson, R, et al.
Julkaistu: (1983)

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type
Tekijä: Wilcock, G, et al.
Julkaistu: (1997)

Frailty in Older Adults with Mild Dementia: Dementia with Lewy Bodies and Alzheimer’s Disease
Tekijä: Miguel Germán Borda, et al.
Julkaistu: (2019-04-01)

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
Tekijä: Chalmers, K, et al.
Julkaistu: (2008)

Vegetable Freshness Perception in Dementia with Lewy Bodies and Alzheimer’s Disease
Tekijä: Yuka Oishi, et al.
Julkaistu: (2020-08-01)

Cortical Lewy Body Dementia
Tekijä: W. R. G. Gibb
Julkaistu: (1990-01-01)

Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
Tekijä: Priyadarshi Prajjwal, et al.
Julkaistu: (2024-04-01)

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
Tekijä: McShane, R, et al.
Julkaistu: (2001)

Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease
Tekijä: Julia Schumacher, et al.
Julkaistu: (2019-01-01)

Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Tekijä: Janna van Wetering, et al.
Julkaistu: (2024-05-01)

Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.
Tekijä: St Clair, D, et al.
Julkaistu: (1994)

Neural basis of false recognition in Alzheimer’s disease and dementia with lewy bodies
Tekijä: Yoshihiro Chadani, et al.
Julkaistu: (2024-09-01)

Structural connectivity is differently altered in dementia with Lewy Body and Alzheimer’s Disease
Tekijä: Stefano eDelli Pizzi, et al.
Julkaistu: (2015-11-01)

Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
Tekijä: Thomas G Beach, et al.
Julkaistu: (2020-01-01)